Providing market intelligence for more than 35 years

In The News

Is Snapchat on the Way Out or Just Finding its Footing?

Predicting what will come for Snap Inc. is a hotter industry topic than trading iPhone rumors. The company's biggest problem isn't the notoriously fickle nature of its target demographic or even the way it's closed approach prevents content from going viral. No, it's biggest problem is that Facebook keeps copying its features and doing them better.

"Facebook and Instagram have added several Snapchat-like features in an effort to drive usage, particularly hoping to pull users away from Snapchat," notes Brett Sappington, senior director of research for Parks Associates. "Facebook knows the digital advertising space well and has a large base of advertising clients. So, ad spending with Facebook and Instagram is seen as a safer bet than Snapchat."

From the article "Is Snapchat on the Way Out or Just Finding its Footing?" by Troy Dreier.

Previously In The News

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

The future of mobile payments – are there too many options that are confusing consumers and merchants?

“Merchants are still slowly upgrading their retail point of sale (POS) systems to support various mobile payment options while new payment options keep showing up. No merchants have provided a complet...

TV Everywhere Usage Grows

A recent article in Multichannel News provided new findings from Parks Associates showing that 40 percent of U.S. pay TV subscribers used TV Everywhere options in 2015, up from 22 percent in 2013. "TV...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...